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published April 4, 2007; doi:10.1152/ajpregu.00105.2007.—Sleep de-
privation is now recognized as an increasingly common condition
inherent to modern society, and one that in many ways, is detrimental
to certain physiological systems, namely, immune function. Although
sleep is now viewed by a significant body of researchers as being
essential for the proper working of a host of defense systems, the
consequences of a lack of sleep on immune function remains to be
fully comprehended. The aim of the current study was to investigate
how paradoxical sleep deprivation (PSD) for 24 and 96 h and sleep
restriction (SR) for 21 days by the modified multiple-platform
method, and their respective 24-h recovery periods, affect immune
activation in rats. To this end, we assessed circulating white blood cell
counts, lymphocyte count within immune organs, as well as Ig and
complement production. The data revealed that PSD for 96 h in-
creased complement C3 and corticosterone concentration in relation
to the control group. In contrast, the spleen weight, total leukocytes,
and lymphocytes decreased during SR for 21 days when compared
with the control group, although production of a certain class of
immunoglobulin, the IgM, did increase. After recovery sleep, lym-
phocyte count in axillary lymph nodes grew when rats had rebound
sleep after PSD for 24 h, neutrophils increased after PSD 96 h and
lymphocytes numbers were higher after SR 21 days. Such alterations
during sleep deprivation suggest only minor alterations of nonspecific
immune parameters during acute PSD, and a significant impairment in
cellular response during chronic SR.
sleep deprivation; immune system; host defenses; leukocytes; immuno-
globulin
THE NUMBER OF PEOPLE WHO EXPERIENCE sleep deprivation (SD) is
on the rise in societies that have a hectic lifestyle. The concept
that modern society is chronically sleep deprived has found
acceptance as of late, and the repercussions of sleep loss across
broad physiological and systemic mechanisms are aspects that
have lured the attention of a significant body of researchers.
Despite the growing amount of literature on the topic, much
remains to be comprehended about the physiological chain of
events that underlie SD (23).
Only recently has the view that sleep is vital in various
defense systems become ubiquitous among investigators. In
spite of some controversy, it is now widely recognized that
sleep loss leads to impairment of those defenses, thus rendering
an organism more susceptible to pathogens (21, 22). SD
expresses comorbidity with disease states in which deregula-
tion of immune variables is considered a principal etiological
or contributory factor (27, 33). Otherwise, during infection,
animals that have robust sleep responses have a better prog-
nosis for survival than those that do not (34).
During normal sleep, there is a redistribution of circulating
lymphocyte subsets and an increase in some aspects of cellular
immunity (4). In contrast, in clinical populations that have
disordered sleep due to stress or a variety of diseases, decrements
in natural and cellular immune function coincide with distur-
bances of detectable sleep architecture and loss of sleep (7, 8, 18,
19). Despite the intuitive understanding that sleep is critical for
health and life, the mechanisms through which SD leads to
impairment of the immune system are poorly elucidated. One of
the most compelling findings associating SD to a breach in the
immune system was reported in a study by Everson (15), in which
an increased rate of bacteremia in rats chronically deprived of
sleep was observed. Bacteria in blood cultures were found in five
of the six rats sleep deprived to near-terminal conditions (15).
Also observed were decreases in lymphocyte counts and natural
killer (NK) cells during SD (5, 16, 28, 31), although in another
study, SD led to increased numbers of lymphocytes and NK cells
(4). Furthermore, an increase in antibody titers was found after SD
in humans (17), rats (14), and mice (29, 30).
Understanding the effects of sleep and SD on the immune
response could shed some light on how the brain affects
immune function. The central feature of sleep is an alteration in
brain function, which is associated with both direct and indirect
changes in other physiological systems (6). In the current
lifestyle, most of the deprivation of sleep occurs in the para-
doxical sleep/rapid eye movement (PS/REM) phase, which
takes place in the second half of the night. For that reason,
many investigators have developed and used different ap-
proaches to reduce or abolish PS; therefore, most investiga-
tions of SD focus on paradoxical sleep deprivation (PSD). Yet
another strategy used to mimic the sleep loss that society is
subjected to is sleep restriction (SR), in which animals are
submitted to gradual loss of sleep during long-term periods,
also representing an important model of sleep consolidation
and adaptation. When allowed to sleep, in both methodologies,
animals compensated for the loss of sleep by spending more
time in PS, which is a consequence of homeostatic sleep
regulation and appears to be proportional to the amount of
sleep lost during the deprivation period (24, 25).
Thus, the aim of this investigation was to examine how
short-term PSD and long-term SR, and their recovery periods,
affect immune activation by assessing circulating white blood
cells, lymphocytes within the immune organs, and immuno-
globulin and complement production.
MATERIALS AND METHODS
Animals
Ninety-day-old male Wistar-Hannover rats were bred and raised in
the animal facility of the Centro de Desenvolvimento de Modelos
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Experimentais para Medicina e Biologia. The animals were housed in
a colony maintained at 22°C with 12:12-h light-dark cycle (lights on
at 0700) and allowed free access to food and water inside standard
polypropylene cages. Rats used in this study were maintained and
treated in accordance with the guidelines established by the Ethical
and Practical Principles of the Use of Laboratory Animals (2).
PSD
The procedure consisted of placing 10 rats in a tiled water tank
(123  44  44 cm) for 24 or 96 h. The tank contained 14 platforms
(6.5 cm in diameters) rising 1 cm above water surface, thus allowing
the rats to move around by leaping from one platform to another. At
the onset of each PS episode, the animal experiences a loss of muscle
tonus and falls into water, thus being awakened. The multiple plat-
form procedure is effective in producing a total suppression of PS. A
significant slow-wave sleep (SWS) loss also occurred throughout the
4 days of SD (31%) (24). It therefore seems appropriate to consider
these animals as being PS-deprived rather than being exclusively
deprived of sleep. The cage control group was maintained in the same
room the experimental rats were in for the duration of the study and
showed normal sleep patterns, PS, SWS, and wake (24). Throughout
the study, the experimental room was maintained under controlled
temperature and a light-dark cycle. Food and water were available ad
libitum, with chow pellets and water bottles provided on a grid located
on top of the tank. The water in the tank was changed daily throughout
the PSD period.
Sleep Restriction
The protocol consisted of submitting the rats to the modified
multiple platform method, as described above for 18 h (beginning at
1600) for 21 days (SR period). After each 18-h sleep deprivation
period, the rats were allowed to sleep for 6 h (sleep window beginning
at 1000). Throughout the SR procedure, rats slept an average of
30–40% of the time, corresponding to 8–9 h per day. This time
interval (1000 to 1600) was chosen because this is when PS attains its
highest expression and when SWS homeostatic pressure is already
yielded (25).
Experimental Procedure
Rats were randomly distributed into four groups: PSD, SR, recov-
ery, and home-cage groups. Seven groups were obtained at the end of
the experiment. The PSD groups PSD 24h and PSD 96h were
subjected to PSD for 24 h (n  10) and 96 h (n  11), respectively.
The SR group SR 21d was subjected to SR for 21 days. The recovery
groups were sleep deprived or sleep restricted and returned to home
cages and were allowed undisturbed, spontaneous sleep for 24h;
corresponding to PSD24R (n  10), PSD96R (n  10) and SR21R
(n  10) groups. Finally, the control group (n  10) was maintained
in separate cages in the same room the experimental rats were housed
during PSD, SR, and recovery procedures and were killed on the same
day the other groups were. By housing all groups in the same room,
we held control of those conditions for all groups. After residing in the
water tanks (PSD and SR groups) or home cages (control and
rebounds group), rats were brought to an adjacent room and decapi-
tated between 0900 and 1200 with minimum discomfort.
Blood Sampling
Blood was collected into sterile tubes containing either liquid
EDTA (differential leukocyte count and plasma corticosterone) or
serum separator medium (immunoglobulin and complement concen-
trations). Differential leukocyte counts were determined in blood on
an automatic blood cell counter (Advia 120 Hematology System,
NY), on the same day that the animals were killed. An aliquot of
blood was centrifuged at 4°C for 15 min at 3,000 rpm. The serum and
plasma were frozen at 80°C until assays were conducted. IgM, IgG,
IgA, and complement C3 and C4 were determined in serum by
nephelometry (Immage Beckman Coulter, Brea, CA). Plasma corti-
costerone (7.1%) concentrations were assayed by a double antibody
radioimmunoassay method specific for rats and mice using a com-
mercial kit (MP Biomedicals, Orangeburg, New York). The sensitiv-
ity of the assay was 0.25 ng/ml.
Spleen Weight and Lymphocyte Counts
Spleen and axillary lymph nodes were removed after the death, and
the spleen weight was immediately measured. For the examination of
cell numbers in spleen and axillary lymph nodes, single cell suspen-
sions were prepared by pressing them through 400-m sterile nylon
mesh. Cells were counted in a Neubauer chamber with the aid of a
microscope by the same previous experimenter.
Statistical Analysis
Values are expressed as means  SE. One-way ANOVA was
performed followed by Duncan’s multiple range test. The level of
statistical significance was set at P  0.05.
RESULTS
Circulating White Blood Cell Count (Leukocyte
Cell Differentials)
Total blood leukocytes. ANOVA test revealed significant
differences among groups [F (6,61)  4,65; P  0.001]. Post
hoc testing indicated that SR for 21 days reduced total leuko-
cytes compared with the control group (P  0.01). PSD for
96 h increased leukocyte population in relation to the PSD 24h
(P  0.03) and SR 21d (P  0.001) groups. Rats subjected to
recovery from PSD 96h had significantly higher concentrations
than those of the PSD24R (P  0.02) and SR21R (P  0.02)
groups (Fig. 1A).
Monocytes. At SR 21d, these cells were significantly de-
creased when compared with those of the PSD 96h group (P
0.01) (Fig. 1B). Monocyte number significantly increased after
recovery from PSD 96h compared with CTRL (P  0.004),
PSD24R (P  0.001), and SR21R (P  0.001), as revealed by
ANOVA [F (6,61)  4.79; P  0.001] followed by Duncan’s
multiple range test.
Neutrophils. Neutrophil values are depicted in Fig. 2A.
An ANOVA test indicated significant differences among
groups [F (6,61) 8.61; P 0.001]. Duncan’s multiple range
test revealed that rats subjected to PSD or SR did not exhibit
significant alterations compared with control rats. However,
recovery from PSD 96h had significantly higher values than
those observed in all other groups: CTRL (P  0.001), PSD
24h (P  0.001), PSD 24R (P  0.001), PSD 96h (P  0.01),
SR 21d (P  0.001), and SR 21R (P  0.001). Neutrophils
were decreased in the SR 21d group compared with the PSD
96h group (P  0.007).
Lymphocytes. Sleep deprivation for 24 h (P 0.001) and SR
for 21 days (P  0.001) significantly reduced the number of
lymphocytes compared with the control group [F (6,61) 
4.00; P  0.001]. The PSD 96h group yielded significantly
higher values than those observed in the PSD 24h (P  0.007)
and SR 21d (P  0.008) groups. Upon recovery, lymphocytes
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were significantly higher compared with respective SR 21d
(P  0.02) as depicted in Fig. 2B.
IgM, IgG, IgA, and Complement C3 and C4
SR for 21 days (P  0.002), as did their recovery period
(P  0.001), significantly increased the IgM concentration
compared with control group [F (6,64)  6.9375; P 
0.00001], as indicated in Fig. 3A. The SR 21d group also
presented increased concentrations of IgM compared with the
PSD 24h (P  0.001) and PSD 96h (P  0.001) groups.
Concentrations of IgM in the SR21R group differed from those
of the PSD24R (P  0.003) and PSD96R (P  0.002) groups.
Complement C3 was higher after PSD24R (P 0.002), PSD
96h (P  0.01), PSD96R (P  0.001) compared with the
control group. PSD 96h yielded significantly higher values
than collected from the PSD 24h (P  0.01) and SR 21d (P 
0.006) groups. PSD24R also increased compared with the PSD
24h (P 0.002) group [F (6,62) 9.1761; P 0.00001] (Fig.
3B). C3 were significantly lower on SR21R group compared
with PSD24R (P  0.001) and PSD96R (P  0.001).
No significant differences among groups were found in the
serum concentrations of IgG, IgA, and Complement C4 (data
not shown), as indicated by ANOVA test.
Spleen Weight
ANOVA test revealed significant differences among groups
[F (6,64)  4.68; P  0.001]. Duncan’s multiple range test
indicated that SR for 21 days significantly reduced spleen
weight compared with all other groups: CTRL (P  0.001),
PSD 24h (P  0.02), PSD 24R (P  0.001), PSD 96h (P 
0.02), PSD96R (P  0.001), and SR21R (P  0.02) (Fig. 4).
Number of Lymphocytes in Spleen and Lymph Nodes
As indicated by the ANOVA test [F (6,63)  6.49; P 
0.0001], the number of lymphocytes in the axillary lymph
nodes significantly increased after recovery from PSD for 24 h
compared with all groups: CTRL (P  0.001), PSD 24h (P 
0.001), PSD 96h (P  0.01), PSD96R (P  0.001), SR 21d
(P  0.001), and SR21R (P  0.001) (Fig. 5). ANOVA test
revealed no significant differences among groups in the num-
ber of cells in the spleen (P  0.05).
Corticosterone
Corticosterone concentrations increased significantly after
PSD for 96 h compared with all other groups: CTRL (P 
0.01), PSD 24h (P  0.01), PSD24R (P  0.001), PSD96R
Fig. 1. Mean values  SE of total leukocytes (A) and monocytes (B) in
home-cage control (CTRL) group and paradoxical sleep-deprived (PSD)
groups for 24 and 96 h and sleep-restricted (SR) groups for 21 days, and their
recovery (R) periods. *Different from the control group; #different from the
PSD 24h group; †different from the PSD24R group; £different from the PSD
96h group; ‡different from the SR 21 day (SR 21d) group; §different from the
SR21R group.
Fig. 2. Mean values  SE of neutrophils (A) and lymphocytes (B) in CTRL
group and PSD groups for 24 and 96 h and SR groups for 21 days, and their
R periods. *Different from the control group; #different from the PSD 24h
group; £different from the PSD 96h group; ‡different from the SR 21d group;
¤different from all groups.
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(P  0.001), SR 21d (P  0.01), and SR21R (P  0.001), as
indicated by ANOVA [F (6,46)  5.57; P  0.0002] (Fig. 6).
DISCUSSION
The SD procedures as used in the present study were
sufficient to produce marked alterations in almost all of the
immune parameters that were examined as indicated in
Table 1. Lymphocyte count decreased after PSD for 24 h,
whereas after 96 h of PSD, increases in C3 and corticosterone
concentrations were observed. The major alterations occurred
in the SR paradigm: spleen weight, total leukocytes, and
lymphocytes decreased in relation to the control group. More-
over, an increase in IgM was also observed in the SR group.
When recovery sleep was evaluated, C3 concentrations in-
creased and lymphocyte count in axillary lymph nodes grew
when rats had rebound sleep after PSD for 24 h. Moreover, the
recovery group of 96 h of sleep loss had increased number of
neutrophils, while presenting lower corticosterone concentra-
tions. Higher spleen weight and number of blood lymphocytes
were observed in the SR21R group. Collectively, the alter-
ations that occurred during SD suggest only minor changes of
nonspecific immune parameters on the short-term periods and
an impairment of cellular response during long-term SR.
The number and proportions of leukocytes in the blood and
immune organs provide an important representation of leuko-
cyte distribution in the body and of the state of activation of the
immune system. A previous study showed that alterations in
immune circulating cells occurred when rats were subjected to
chronic SD by the disk-over-water method (14). However, the
methodology that was adopted in that study had the animal
move about to maintain wakefulness, and physical exercise
was added as a variable of that investigation.
Leukocytosis induced by SD has been a consistent finding in
human sleep loss studies since at least 1925, sometimes com-
posing the only physiological finding (20). In contrast, other
reports with humans corroborate our findings with animal
experimentation and did not show significant differences in
circulating monocytes and neutrophils after SD. In a human
study using SD for 48 h, these leukocytes did not show any
significant difference during the SD procedure (28).
Consistent with our findings, previous studies have shown
decreased circulating lymphocytes counts after SD (5, 31). The
spleen is a critical immune organ, which has been shown to
increase in size after immune activation due to B and/or T cell
differentiation and proliferation. Thus, post mortem spleen
weights provide a rough estimate of the degree of immune
activation (13). To our knowledge, few studies have focused on
spleen weight and number of lymphocytes in spleen and
axillary lymph nodes related to sleep and/or SD. In this sense,
our study demonstrated that only chronic SR resulted in reduc-
tion in spleen weight, which was reverted after recovery. In
common, these studies raise the hypothesis that the degree, the
methodology, and the duration of SD are important in deter-
mining its effects on immune function.
Ig and complement levels in serum are part of the data used
to assess the integrity of immune system functioning and are
essential in the understanding of the impairment and restorative
processes occurring during wakefulness and sleep. In this
context, the current data are in agreement with previous find-
ings demonstrating an increase in C3 concentration in acute SD
Fig. 3. Mean values SE of IgM (A) and C3 (B) in the CTRL group and PSD
group for 24 and 96 h and SR group for 21 days, and their R periods.
*Different from the control group; #different from the PSD 24h group;
†different from the PSD 24R group; £different from the PSD 96h group;
¢different from the PSD 96R group; ‡different from the SR 21d group.
Fig. 4. Mean values  SE of spleen weight in CTRL groups and PSD groups
for 24 and 96 h and SR groups for 21 days, and their R periods. ¤Different
from all groups.
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humans (17) and that IgM was the first Ig to increase in chronic
SD rats (14). No differences between groups were found in the
serum concentrations of IgG, IgA, and complement C4.
Studies have shown that alteration in leukocyte distribution
is mediated by hormones released by the adrenal gland, like
corticosterone. It may be worth noting that most stress condi-
tions, which are found to be immunoenhancing, involve acute
stress, and those that are found to be immunosuppressive
involve chronic stress (with the effects of stress on leukocyte
distribution being an important factor to be taken into account)
(9, 12, 32, 35). SD is an inherently stressful procedure, and it
may not be possible to completely extricate the effects of SD
from general nonspecific stress effects (1, 3). There is some
evidence that there are reciprocal relationships between im-
mune function and increased hypothalamic-pituitary-adreno-
cortical axis activity in depression (26) and in stress response
(10, 11, 12).
A question remained as to whether the observed alteration in
immune parameters was caused by sleep loss or by stress
inherent to the present methodology. Chronic SR for 21 days
by the modified multiple platform method did not alter the
concentration of corticosterone but did cause the most signif-
icant alterations in immune cells, demonstrating that method-
ology stress did not lead to those alterations, which were
attributed to sleep loss per se. Of note is that although some
immune parameters recovered their normal values rather rap-
idly, others remained altered, indicating that sleep normaliza-
tion (i.e., recovery) is not the sole factor that leads to the
recovery of homeostasis.
Although SD is considered a risk factor for human disease,
and some specific health impairments have been linked to SD,
it is a condition that increases progressively in current society,
in which the population tends to sleep less due to social
pressure. Thus, sleep fragmentation associated to the SD
method is a condition that mimics the human lifestyle of
restricted sleep time and prolonged wakefulness, making that
animal model ideal for studies of sleep and sleep loss.
In the present study, however, the two experimental methods
used showed distinct effects in immune system: PSD for 24 h
caused only a decrease of blood lymphocytes and PSD for 96 h
resulted in an increase of C3 concentration. In contrast, SR for
21 days decreased total leukocytes, lymphocytes, and spleen
weight and increased unspecific IgM production. In conclu-
sion, the present findings indicate that sleep and sleep loss play
an important role exerting differing physiological influence in
the modulation of immunity. Our data suggest that although
acute sleep loss as that described in our PSD protocol causes
minor alterations in some immune parameters, prolonged SR
like that observed in a modern population on a daily basis,
causes impairment of systemic circulation of leukocytes and
quite possibly increases the susceptibility to infectious dis-
eases.
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Fig. 5. Mean values SE of the number of lymphocytes in the axillary lymph
nodes in CTRL groups and paradoxical PSD groups for 24 and 96 h and SR
groups for 21 days, and their R periods. ¤Different from all groups.
Fig. 6. Mean values  SE of corticosterone concentrations in CTRL and PSD
groups for 24 and 96 h and SR groups for 21 days, and their R periods.
¤Different from all groups.
Table 1. Summary of obtained results of PSD groups for 24
and 96 h and SR groups for 21 days compared with control
and between R and respective PSD/SR groups
PSD 24 h PSD 96 h SR 21 Days
Control
Total blood leukocytes 2
Monocytes
Neutrophils
Lymphocytes 2 2
IgM 1
C3 1
Spleen weight 2
Number of lymphocytes in lymph nodes
Corticosterone 1
PSD24R PSD96R SR21R
R and PSD/SR Groups
Total blood leukocytes
Monocytes
Neutrophils 1
Lymphocytes 1
IgM
C3 1
Spleen weight 1
Number of lymphocytes in lymph nodes 1
Corticosterone 2
PSD, paradoxical sleep deprived; SR, sleep-restricted; R, recovery groups.
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